Accreditation Statistics

As of May 2, 2024

Cellular Therapy Entities

  • Accredited: 262
  • Applicants: 30

Cord Blood Banks

  • Accredited: 48
  • Applicants: 10


Initial Accreditations

  • Abu Dhabi Stem Cell Center, Abu Dhabi, United Arab Emirates | Cellular Therapy Product Processing with Minimal Manipulation
  • CHN - Complexo Hospitalar de Niterói, Rio de Janeiro, Brazil | Adult and Pediatric Allogeneic and Autologous Hematopoietic Progenitor Cell Transplantation, Marrow and  Peripheral Blood Cellular Therapy Product Collection, and Cellular Therapy Product Processing with Minimal Manipulation


A complete list of accredited organizations can be found at

Comments Requested on Draft Eighth Edition NetCord-FACT Cord Blood Banking Standards

Posted in :: 2023 Volume 4 :: Thursday, July 27th, 2023






By Monique Summers
, RN, MSN, MPA, FACT Standards Development Manager

FACT has published the draft eighth edition NetCord-FACT International Standards for Cord Blood Collection, Banking, and Release for Administration for public comment through September 15, 2023.

These comprehensive Standards promote quality medical and laboratory practices throughout all phases of cord blood collection, processing, and banking to consistently achieve quality placental and umbilical cord blood units for administration and to improve patient outcomes. These Standards are applicable to both unrelated donor units and family units and cover 1) collection of cord blood cells, regardless of the methodology or site of collection; 2) screening, testing, and eligibility determination of the maternal and infant donor according to Applicable Law; 3) all phases of processing, cryopreservation, and storage; 4) testing and characterization of the cord blood unit; 5) making the cord blood unit available for administration, either directly or through listing with a search registry; 6) the search process for selection of specific cord blood units; 7) reservation and release of cord blood units for clinical use; 8) transport or shipment of fresh or cryopreserved cord blood units; and 9) clinical follow up. The final Standards will be published in December 2023.

The purpose of this public comment period is to receive your comments and suggestions on this edition of the Standards. The published draft is a redline document intended to highlight the significant changes. Some changes are new standards; however, others are intended to clarify rather than change the intent, or to provide consistency with other sets of FACT Standards. Minor reorganization and clarifications are not tracked.

Review the Draft Eighth Edition Cord Blood Standards

For instructions and to submit your comments(s), go to the Cord Blood Public Comments Survey.